Stanley J. Szefler, MD

Professor of Pediatrics
University of Colorado School of Medicine
Aurora, Colorado, United States

● Astra Zeneca (Currently Ongoing) (Products/Services: Consultant) ● GlaxoSmithKline (Ended In the Past 24 Months) (Products/Services: Advisory Committee) ● Moderna (Currently Ongoing) (Products/Services: Consultant) ● Propeller Health (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator) ● Regeneron (Currently Ongoing) (Products/Services: Consultant) ● Sanofi (Ended In the Past 24 Months) (Products/Services: Advisory Committee)

Presentation(s):

• Efficacy of Dupilumab in Children With Uncontrolled, Moderate-to-Severe Type 2 Asthma, With/Without Evidence of Allergic Asthma: The VOYAGE Phase 3 Study

  Sunday, April 24, 2022
  10:00 AM – 10:15 AM US MT